Cargando…
Biocompatible Drug Delivery System Based on a MOF Platform for a Sustained and Controlled Release of the Poorly Soluble Drug Norfloxacin
[Image: see text] Norfloxacin (NFX), an important antibacterial fluoroquinolone, is a class IV drug according to the biopharmaceutics classification system (BCS) and has low solubility and permeability issues. Such poor physicochemical properties of drug molecules lead to poor delivery and are of se...
Autores principales: | Yadav, Preety, Kumari, Sarita, Yadav, Anand, Bhardwaj, Priya, Maruthi, Mulaka, Chakraborty, Anindita, Kanoo, Prakash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413448/ https://www.ncbi.nlm.nih.gov/pubmed/37576664 http://dx.doi.org/10.1021/acsomega.3c02418 |
Ejemplares similares
-
Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system
por: Dave, Vivek, et al.
Publicado: (2017) -
Simultaneous Spectrophotometric Estimation of Norfloxacin and Ornidazole in Tablet Dosage Form
por: Wankhede, S. B., et al.
Publicado: (2009) -
Norfloxacin sesquihydrate
por: Ravindra, Nittala V., et al.
Publicado: (2009) -
Advances in aggregation induced emission (AIE) materials in biosensing and imaging of bacteria
por: Maruthi, Mulaka, et al.
Publicado: (2021) -
Norfloxacin-Loaded Electrospun Scaffolds: Montmorillonite Nanocomposite vs. Free Drug
por: Faccendini, Angela, et al.
Publicado: (2020)